M2698 has the potential to block the AKT compensatory feedback loop while avoiding the adverse effects of pan-AKT inhibition, including those associated with AKT2 inhibition (e.g., hyperglycemia) [22–25]. The gene discussed is AKT1; the disease is Hyperglycemia.